{
  "trial_id": "NCT03149289",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "hemoglobinopathies",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "chronic hepatitis due to HCV",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "fibrosis (Fibroscan stiffness \u226510 kPa) or bioptic evaluation of cirrhosis within 6 months previously",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "extrahepatic manifestations of chronic hepatitis C virus infection",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "active cancer, including hepatocellular carcinoma",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "pregnant or lactating females",
      "label": "does_not_trigger",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient has chronic HCV infection and is on combination therapy. No evidence of alcoholic liver disease, bleeding from esophageal varices, hemochromatosis, autoimmune hepatitis or metabolic liver disease.",
  "_meta": {
    "topic_id": "27",
    "trial_id": "NCT03149289",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}